In particular, patients with Fabry's disease often have pale gray, yellow, or brown streaks on the cornea of their eye. These streaks are known as corneal opacities or corneal verticillata.

Expert Rev Ophthalmol. 2008;3(2):177-192. Clinically, cornea verticillata associated with amiodarone, (hydroxy-)chloroquine and Fabry's disease may be difficult to discriminate. As Fabry's disease ...

Amicus Therapeutics’ first oral drug for the rare condition Fabry disease has been approved by the FDA, giving patients an alternative to conventional injected enzyme replacement therapy.

Sangamo's phase 1/2 STARR study data using isaralgagene civaparvovec targeting patients with Fabry Disease is expected in H1 2025. Learn more on SGMO stock here.

Experts And Viewpoints, August 23, 2021 Metagenomics May Enhance the Diagnosis of Infectious Keratitis Dr Christopher Rapuano evaluates a new study comparing standard corneal cultures with ...

Narrator With the help of an innovative procedure known as dsaek, Jolie will have the damaged portion of his cornea replaced by eye surgeon Rick Fraunfelder of Portland's Casey Eye Institute.

Sangamo Therapeutics has identified a shortcut to market for its Fabry disease candidate, aligning with the FDA on a pathway that could slash three years from the time to market and free it from ...

Italian pharma Chiesi has begun a new rare diseases division as it builds towards a potential commercial launch for its Fabry Disease therapy. Chiesi, which is best known for its respiratory drugs ...

Dry eye disease is a very real condition that impacts 16 million Americans. Here, MDs explain dry eye causes, symptoms, and ...

Eye care specialists could see artificial intelligence help in diagnosing infectious keratitis (IK), a leading cause of ...

It began with a burning pain in her right eye. At first, Elisabeth Cohen thought she’d gotten something in it. But the next ...